Pharma-bio Serv Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Pharma-bio Serv Inc (PBSV) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Pharma-bio Serv Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 9M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (-1.5% annualized vs trailing 12 months).
- Peer revenue share: Pharma-bio Serv Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
PBSV Sales vs. its Competitors, Q3 2026
Pharma-bio Serv Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Consulting Services industry grew revenue 9.9% year over year, combined, vs 19.0% for Pharma-bio Serv Inc. Pharma-bio Serv Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.
